Legislative Proposal, Bill or Resolution, Regulation
Food and Drugs Act and Reguatloins, specifically with respect to approval, regulation and life-cycle management of therapetuic products.
Policies or Program
Federal public drug plans, specficially the Non-Insured Health Benefits program (Health Canada), with respect to decisions and policies that impact reimbursement of therapeutic products for plan beneficiaries.
Invest in Canada policies and programs with respect to investment, business development and innovation in the life sciences industry sector.
Science and Technology Strategy led by Industry Canada, particularly with respect to the life sciences priority under the S&T Strategy.